Javelin Pharmaceuticals Inc. said Thursday it accepted a tender offer by Hospira Inc. to buy about 79 percent of the company’s shares. Under the offer, which expired on Wednesday at midnight, Hospira will purchase about 51.3 million shares at $2.20 per share. Javelin said the merger is expected to be completed by Friday. Get the full story »
Javelin
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
